Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma.
Journal: Future oncology (London, England)
Published: July 14, 2026
Community health assessment and monitoring in the pharmacy (CHAMP): Protocol for a randomized stepped-wedge trial of lung cancer screening in community pharmacies.
Journal: Contemporary clinical trials
Published: May 12, 2026
Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy.
Journal: International journal of hematology
Published: April 14, 2026
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Cardiotoxicity of T cell immunotherapies.
Journal: Nature reviews. Cardiology
Published: February 08, 2026
Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3.
Journal: Cancer
Published: January 16, 2026
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 09, 2025
Allogeneic chimeric antigen receptors (CARs) as an "off-the-shelf" therapy in multiple myeloma.
Journal: Immunotherapy
Published: February 17, 2025
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2025
Last Updated: 09/26/2026